July 30 (Reuters) - Redcare Pharmacy NV RDC.DE :
* EQS-NEWS: REDCARE PHARMACY ACHIEVES RAPID INCREASE OF RX
SALES
IN GERMANY, CONTINUES ITS STRONG DOUBLE-DIGIT OVERALL GROWTH
RATE AND CLOSES Q2 WITH A SOLID 2.7% MARGIN.
* ON TRACK TO MEET ALL ELEMENTS OF FULL-YEAR GUIDANCE
* ADJUSTED. EBITDA OF EUR 27M IN H1 (H1 2023: EUR 22M)
RESULTING
IN A MARGIN OF 2.4%; IN Q2, EUR 15M (H1 2023: EUR 13M)
Source text for Eikon: ID:nEQ4TJpp8a
Further company coverage: RDC.DE
((Reuters.Briefs@thomsonreuters.com;))